Hepatitis B Screening, Prophylaxis and Reactivation in the Era of Rituximab-based Chemotherapy

Hepatitis B reactivation is a well-described complication in patients with inactive chronic hepatitis B receiving chemotherapy. Screening for HBV and preemptive therapy are recommended. However, the rates of HBV screening, prophylaxis and reactivation during rituximab-containing chemotherapy are unk...

Full description

Saved in:
Bibliographic Details
Main Authors: Méndez-Navarro, Jorge, Corey, Kathleen E., Zheng, Hui, Barlow, Lydia L., Jang, Jae Young, Lin, Wenyu, Zhao, Hong, Shao, Run-Xuan, McAfee, Steven L., Chung, Raymond T.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3736143/
https://ncbi.nlm.nih.gov/pubmed/20738779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1478-3231.2010.02332.x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items